Real-world use of multiplex point-of-care molecular testing or laboratory-based molecular testing for influenza-like illness in a 2021 to 2022 US outpatient sample.

Show other versions (1)

While molecular testing is recommended for symptomatic patients suspected of having coronavirus disease 2019 (COVID-19), limited data are available examining real-world use of tests for severe acute respiratory syndrome coronavirus (SARS-CoV-2) and the impact of SARS-CoV-2 testing on patient outcome...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Karen M Stockl, Jamie Tucker, Anne Beaubrun, Julia M Certa, Laura Becker, Jordan G Chase
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Online Access:	https://doi.org/10.1371/journal.pone.0313660

Similar Items

Real-world use of multiplex point-of-care molecular testing or laboratory-based molecular testing for influenza-like illness in a 2021 to 2022 US outpatient sample
by: Karen M. Stockl, et al.
Published: (2024-01-01)

Utility of Rapid Influenza Molecular Testing in an Outpatient Hemodialysis Unit: A Prospective Cohort Study
by: Matthew Kadatz, et al.
Published: (2020-02-01)

Cost-of-illness comparison between clinical judgment and molecular point-of-care testing for influenza-like illness patients in Germany
by: M. Brachmann, et al.
Published: (2023-01-01)

Sexually transmitted infection laboratory testing and education trends in US outpatient physician offices, 2009–2016
by: Kelly R Reveles, et al.
Published: (2021-08-01)

End-of-Season Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Outpatient Settings, Beijing, China: A Test-Negative Design
by: Jiaojiao Zhang, et al.
Published: (2025-07-01)

Evaluation of Four Commercial Multiplex Molecular Tests for the Diagnosis of Acute Respiratory Infections.
by: Nicolas Salez, et al.
Published: (2015-01-01)

Analytical comparison of over-the-counter multiplex tests for influenza A, influenza B, and SARS-CoV-2
by: Sarah Lohsen, et al.
Published: (2026-06-01)

The US FDA's proposed rule on laboratory-developed tests: Impacts on clinical laboratory testing
by: Leslie Smith, et al.
Published: (2024-05-01)

Molecular-based laboratory testing confer accuracy over microscopical testing for tick identification
by: Isaac Singh, et al.
Published: (2025-04-01)

The epidemiology of pediatric outpatient acute respiratory tract infections in the US: a multi-facility analysis of multiplex PCR testing from 2018 to 2023
by: Tristan T. Timbrook, et al.
Published: (2024-01-01)

Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing
by: Arti Easwar, et al.
Published: (2021-10-01)

A Multi-Laboratory Evaluation of Commercial Monkeypox Virus Molecular Tests
by: Oran Erster, et al.
Published: (2023-06-01)

Evaluating the Effectiveness of External Molecular Proficiency Testing in the Global Polio Laboratory Network, 2021–2022
by: Nancy Gerloff, et al.
Published: (2024-11-01)

Development of a multiplex isothermal amplification molecular diagnosis method for on-site diagnosis of influenza
by: Woong Sik Jang, et al.
Published: (2020-01-01)

Development of a multiplex isothermal amplification molecular diagnosis method for on-site diagnosis of influenza.
by: Woong Sik Jang, et al.
Published: (2020-01-01)

Multiplexed on-site sample-in-result-out test through microfluidic real-time PCR (MONITOR) for the detection of multiple pathogens causing influenza-like illness
by: Yi Yang, et al.
Published: (2023-12-01)

The laboratory billing process and its applications to molecular microbiology testing: guidance for laboratorians
by: Meghan W. Starolis, et al.
Published: (2025-10-01)

Laboratory capacity in COVID-19 diagnosis and the need to enhance molecular testing in Ghana
by: Godfred Acheampong, et al.
Published: (2021-01-01)

Physical health examination in outpatients with schizophrenia: the cost effectiveness of laboratory screening tests
by: Saana Eskelinen, et al.
Published: (2020-12-01)

Air pollutants and outpatient visits for influenza-like illness in Beijing, China
by: Xiaoguang Li, et al.
Published: (2021-06-01)

Smallpox Vaccination of Laboratory Workers at US Variola Testing Sites
by: Sharon Medcalf, et al.
Published: (2015-08-01)

Collage of cases and brief review of the laboratory diagnosis and molecular testing in autoimmune haemolytic anaemia
by: Harkiran Arora, et al.
Published: (2024-01-01)

Primary Vitreoretinal Lymphoma: Current Diagnostic Laboratory Tests and New Emerging Molecular Tools
by: Beatrice Melli, et al.
Published: (2022-09-01)

Molecular Testing in Microbiology
by: Alison M. kesson
Published: (2016-02-01)

Effectiveness of the influenza vaccine for preventing laboratory-confirmed influenza infections in outpatient immunocompromised adults, 2017–2018
by: Kailey Hughes Kramer, et al.
Published: (2024-12-01)

Influenza A and B in a cohort of outpatient children and adolescent with influenza like-illness during two consecutive influenza seasons
by: Clarisse M. Machado, et al.
Published: (2020-01-01)

Qualitative evaluation of a molecular point-of-care testing study for influenza in UK primary care
by: Charis Xuan Xie, et al.
Published: (2024-12-01)

A multiplex two-color real-time PCR method for quality-controlled molecular diagnostic testing of FFPE samples.
by: Jiyoun Yeo, et al.
Published: (2014-01-01)

Impact of the COVID-19 pandemic and multiplex polymerase chain reaction test on outpatient antibiotic prescriptions for pediatric respiratory infection.
by: Daisuke Kitagawa, et al.
Published: (2023-01-01)

Molecular diagnostics of prostate cancer: impact of molecular tests
by: Eros Azzalini, et al.
Published: (2024-10-01)

Thyroid and Molecular Testing. Advances in Thyroid Molecular Cytopathology
by: Esther Diana Rossi, et al.
Published: (2021-03-01)

Molecular Diagnostic Tests for Microsporidia
by: Kaya Ghosh, et al.
Published: (2009-01-01)

Molecular Testing for Gastrointestinal Cancer
by: Hye Seung Lee, et al.
Published: (2017-03-01)

Clinical evaluation of a fully automated and high-throughput molecular testing system for detection of influenza virus
by: Kosuke Kosai, et al.
Published: (2022-11-01)

Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting.
by: Joyce H S You, et al.
Published: (2017-01-01)

Expanded PCR Panel Testing for Identification of Respiratory Pathogens and Coinfections in Influenza-like Illness
by: Pallavi Upadhyay, et al.
Published: (2023-06-01)

Molecular epidemiological analysis of Influenza viruses in Influenza-like illness cases: a retrospective study in Chongqing Hi-Tech Zone, China (2021–2024)
by: Wei Cai, et al.
Published: (2024-12-01)

Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design
by: Richard K. Zimmerman, et al.
Published: (2023-01-01)

The added value of serologic testing: A comparison of influenza incidence among pregnant persons based on molecular-based surveillance versus serologic testing
by: Wanitchaya Kittikraisak, et al.
Published: (2024-12-01)

The feasibility and acceptability of integrating hepatitis C and HIV diagnostic testing on centralized molecular laboratory platforms in Myanmar.
by: Thandar Su Naing, et al.
Published: (2023-01-01)